U.S. Exosomes Market Size & Outlook, 2023-2030
U.S. exosomes market, 2018-2030 (US$M)
Related Markets
U.S. exosomes market highlights
- The U.S. exosomes market generated a revenue of USD 73.6 million in 2023 and is expected to reach USD 576.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 34.2% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Exosomes market data book summary
| Market revenue in 2023 | USD 73.6 million |
| Market revenue in 2030 | USD 576.9 million |
| Growth rate | 34.2% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Kits & Reagents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Instruments, Services |
| Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
Other key industry trends
- In terms of revenue, U.S. accounted for 52.1% of the global exosomes market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. exosomes market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 576.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Exosomes Market Scope
Exosomes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. exosomes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to exosomes market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 44.97% in 2023. Horizon Databook has segmented the U.S. exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Exponential growth in the number of exosomes research projects in the U.S. has encouraged the entry of new market players in the region. For instance, in November 2015, University of Texas MD Anderson Cancer Center established Codiak Bio Sciences in collaboration with Broad Institute of MIT and Harvard University.
Another factor anticipated to contribute to the growth of the U.S. market is the ongoing IP-related activities in this country pertaining to the development of exosomes applications. For instance, in December 2016, Creative Medical Technology Holdings announced the filing of a U.S.
Patent application titled Treatment of Stroke by Amniotic Fluid Derived Stem Cell Conditioned Media and Products Derived There of. This patent application covers the usage of the company Amnio Stem stem cell for the production of exosomes that can regenerate damaged brain tissues after stroke.
Reasons to subscribe to U.S. exosomes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. exosomes market databook
-
Our clientele includes a mix of exosomes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. exosomes market , including forecasts for subscribers. This country databook contains high-level insights into U.S. exosomes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. exosomes market size, by product, 2018-2030 (US$M)
U.S. Exosomes Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
